Skip to content
Open access

Macrophage-derived IL-27 sustains autoreactive CD8+ cytotoxic T cells in autoimmune hepatitis

Sep 2026 · bioRxiv · 0 citations
Biology Medicine

TL;DR

These findings define a novel mechanism for sustaining autoreactive T cells in the liver via TLR9-driven macrophage-induced IL-27 circuit that sustains a functional, self-renewing autoreactive PD1+ CD8⁺ T cell program in situ.

Abstract

Chronic or persistent T cell activation is widely thought to culminate in T cell exhaustion, yet how autoreactive CD8⁺ T cells remain functionally intact despite sustained self-antigen exposure is poorly understood. In chronic infection and cancer this durability is attributed to stem-like, TCF1⁺ PD-1⁺ progenitor-exhausted (Tpex) cells that reside in lymphoid tissue and continuously replenish functional effectors; whether such a reservoir operates within a chronically inflamed peripheral organ during sterile autoimmunity is unknown. Here we show that mice lacking the lysosomal nuclease DNase2a together with the type I interferon receptor Ifnar1 (Dnase2a⁻/⁻Ifnar1⁻/⁻) develop spontaneous, progressive hepatic inflammation. This hepatitis was dependent on the endosomal DNA sensor TLR9, identifying self-DNA as the initiating ligand. Inflammation was marked by expansion of inflammatory macrophages and accumulation of CD8⁺ T cells co-expressing PD-1 and TOX that retained, rather than lost, effector function. Paired single-cell TCR and transcriptomic analysis revealed progenitor-exhausted T cells within the liver itself that shared clonotypes with clonally expanded PD-1+ TOX+ T cells, defining a locally operating progenitor-to-effector pipeline. Spatial transcriptomics positioned these intrahepatic T cell clusters adjacent to IL-27–expressing inflammatory macrophages, and disruption of IL-27 or its receptor in bone marrow–derived cells reduced PD-1⁺ CD8⁺ T cells and their effector functions. These findings define a novel mechanism for sustaining autoreactive T cells in the liver via TLR9-driven macrophage-induced IL-27 circuit that sustains a functional, self-renewing autoreactive PD1+ CD8⁺ T cell program in situ.

Read PDF

Similar papers

Review Open access Sep 2026

CD4+ cytotoxic T cells: context-dependent effectors in health and disease

This review highlights recent advances in understanding the development, regulation, and effector functions of CD4 + CTLs, while also addressing the limitations and challenges in targeting them therapeutically.

Hao-Yang Yu, Jia-Xin Liang, Qi-Xuan Gu et al. · 0 citations
Open access Sep 2026

Antigen-specific regulatory T cells eliminate cognate CD4 effector T cells through perforin, granzyme B, and Bim.

T cells (Tregs) maintain immune tolerance, yet how they selectively eliminate cognate CD4+ effector T cells remains unclear. We propose a co-activation-dependent elimination mechanism, conceptually akin to synthetic lethality. Using in vitro co-cultures, we show that simultaneous peptide-MHC II recognition by Tregs and...

Yan-Yu Ye, Hao-Yue Zheng, Jia-Qi Duan et al. · 0 citations
Review Nov 2026

T cell exhaustion in cancer.

Yin Min Thu, Yosuke Togashi · 1 citation
Review Open access Nov 2026

Macrophages in T cell-mediated rejection of renal allografts: pathological mechanisms and CAR-macrophage immunotherapy

Abstract Acute T cell-mediated rejection (TCMR) remains an important cause of early and intermediate-term graft dysfunction after kidney transplantation. As effector cells that bridge innate and adaptive immunity, macrophages are deeply implicated in the initiation, progression, and fibrotic sequelae of TCMR. This revi...

Guo-Hang He, Jian-Bo Qing, Gu-Ming Chen et al. · 0 citations
Open access Oct 2026

IL-2-Producing Tfh Cells Sustain Treg Cell Homeostasis and Immune Tolerance in the Gut

Follicular helper T (TFH) cells are well known for their role in supporting B cell responses. Here, we identify a critical B cell-independent function for TFH cells in sustaining regulatory T (Treg) cells within gut-associated lymphoid tissues (GALT). We demonstrate that TFH cells produce interleukin-2 (IL-2) at the T...

Shivangi Dave, Holly Bachus, Nathan Santiago et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.